US Stock MarketDetailed Quotes
FWBI First Wave BioPharma
- 2.6800
- -0.0600-2.19%
Close Apr 29 16:00 ET
- 2.5400
- -0.1400-5.22%
Post 18:45 ET
5.43MMarket Cap-55P/E (TTM)
2.9600High2.6500Low36.43KVolume2.8200Open2.7400Pre Close102.26KTurnover1.91%Turnover RatioLossP/E (Static)2.03MShares62.400052wk High1.51P/B5.12MFloat Cap2.420052wk Low--Dividend TTM1.91MShs Float235200.0000Historical High--Div YieldTTM11.31%Amplitude2.4200Historical Low2.8070Avg Price1Lot Size
First Wave BioPharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 44.60%-12.38M | 38.50%-3.44M | 21.69%-3.33M | 39.77%-2.76M | 64.03%-2.85M | 30.80%-22.34M | 4.61%-5.59M | 72.95%-4.25M | 18.45%-4.59M | -55.95%-7.91M |
| Net income from continuing operations | -7.97%-15.79M | -2.88%-4.1M | -178.20%-3.43M | 22.54%-4.19M | 57.72%-4.07M | 75.01%-14.63M | 64.32%-3.99M | 114.44%4.39M | 41.72%-5.41M | -25.26%-9.63M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | 20.47%1.71M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 0.01%29.27K | 0.01%7.32K | 0.00%7.32K | 0.01%7.32K | 0.01%7.32K | -94.60%29.27K | -94.67%7.32K | -94.71%7.32K | -94.53%7.32K | -94.49%7.32K |
| Other non cash items | -43.40%157.02K | -65.28%33.59K | 514.83%92.1K | -32.75%15.81K | -89.08%15.53K | -91.99%277.43K | -96.40%96.76K | -87.88%14.98K | 106.11%23.51K | -86.25%142.19K |
| Change In working capital | 120.86%2.19M | 114.10%494.53K | 97.03%-259.8K | 166.72%1.11M | -37.35%843.91K | -161.41%-10.5M | -151.86%-3.51M | -161.57%-8.76M | -88.40%416.81K | 100.17%1.35M |
| -Change in receivables | 200.00%93.01K | --0 | --0 | 147.20%20K | 360.25%73.01K | -116.87%-93.01K | --98.97K | ---121.56K | -107.94%-42.37K | -259.48%-28.06K |
| -Change in prepaid assets | 575.68%719.26K | 27.78%-560.19K | 19,337.85%433.46K | 26.96%334.6K | 42.55%511.39K | -337.02%-151.21K | 12.29%-775.73K | -99.19%2.23K | 325.25%263.54K | -41.35%358.76K |
| -Change in payables and accrued expense | 114.31%1.45M | 138.31%1.08M | 92.38%-657.23K | 235.58%755.57K | -74.19%275.27K | -161.81%-10.15M | -484.13%-2.82M | -161.86%-8.62M | -91.66%225.16K | 312.84%1.07M |
| -Change in other current liabilities | 33.64%-74.05K | -66.53%-23.8K | -103.97%-36.04K | 105.25%1.55K | 68.55%-15.77K | -258.74%-111.6K | 44.46%-14.29K | -228.64%-17.67K | -109.94%-29.51K | 76.65%-50.13K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 44.60%-12.38M | 38.50%-3.44M | 21.69%-3.33M | 39.77%-2.76M | 64.03%-2.85M | 30.80%-22.34M | 4.61%-5.59M | 72.95%-4.25M | 18.45%-4.59M | -55.95%-7.91M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -500K | 0 | ||||||||
| Net intangibles purchase and sale | ---500K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---500K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -3.26%15.23M | -21.10%4.36M | 12.90%5.39M | 2,431.33%1.93M | -33.91%3.55M | -64.84%15.74M | -67.64%5.52M | -67.88%4.77M | -95.71%76.38K | -51.43%5.37M |
| Net issuance payments of debt | 5.89%-603.49K | --0 | 5.21%-153.48K | 5.79%-226.91K | 6.44%-223.1K | -821.86%-641.24K | --0 | -16.01%-161.91K | -16.07%-240.86K | -16.14%-238.47K |
| Net common stock issuance | -31.32%15.83M | 39.53%10.3M | -75.13%1.83M | -124.88%-78.94K | -52.71%3.77M | -29.44%23.05M | 19.47%7.39M | -54.62%7.37M | -72.99%317.23K | -12.00%7.97M |
| Net preferred stock issuance | --0 | --0 | ---- | ---- | ---- | -97.20%199K | ---1 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -98.64%657 | -1,464,564.53%-5.95M | 790,489.77%3.71M | --2.24M | -99.38%301 | -99.01%48.42K | --406 | ---469 | --0 | -98.95%48.48K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---6.91M | ---1.86M | -111.09%-2.64M | -100.00%1 | 74.67%-2.41M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -3.26%15.23M | -21.10%4.36M | 12.90%5.39M | 2,431.33%1.93M | -33.91%3.55M | -64.84%15.74M | -67.64%5.52M | -67.88%4.77M | -95.71%76.38K | -51.43%5.37M |
| Net cash flow | ||||||||||
| Beginning cash position | -83.22%1.38M | 97.43%3.31M | 8.88%1.26M | -63.37%2.09M | -83.22%1.38M | 36.07%8.25M | -76.72%1.68M | -85.70%1.16M | -52.64%5.69M | 36.07%8.25M |
| Current changes in cash | 135.56%2.35M | 716.38%419.44K | 297.22%2.06M | 81.63%-828.38K | 127.57%701.53K | -406.36%-6.6M | -107.07%-68.05K | 159.58%517.66K | -15.19%-4.51M | -142.58%-2.54M |
| Effect of exchange rate changes | --0 | --0 | --0 | --0 | --0 | -944.43%-259.71K | -397.39%-226.05K | 18.38%5.85K | 15.66%-30.75K | 36.17%-8.77K |
| End cash Position | 169.66%3.73M | 169.66%3.73M | 97.43%3.31M | 8.88%1.26M | -63.37%2.09M | -83.22%1.38M | -83.22%1.38M | -76.72%1.68M | -85.70%1.16M | -52.64%5.69M |
| Free cash flow | 42.37%-12.88M | 29.56%-3.94M | 21.69%-3.33M | 39.77%-2.76M | 64.03%-2.85M | 47.56%-22.34M | 65.29%-5.59M | 72.95%-4.25M | 19.50%-4.59M | -55.95%-7.91M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg